LUSEDRA
LOE ApproachingNDAINTRAVENOUSSOLUTION
Approved
Dec 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5
Data completeness
2/8 — Basic
Drug data last refreshed 11h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LUSEDRA is an intravenous small-molecule solution approved by the FDA in December 2008 as an NDA. The specific indication, mechanism of action, and therapeutic class are not publicly detailed in available data. It is administered as an IV solution for patient populations requiring parenteral drug delivery.
LOE Approaching
With LOE approaching and moderate competitive pressure (30% competitive intensity), the brand team is likely transitioning to defensive positioning and cost-optimization strategies rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (5)
Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia
Started Jun 2011
0Interstitial Cystitis
Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
Started Feb 2011
13 enrolled
Procedural SedationRegional Anesthesia BlockOrthopedic Surgery
A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion
Started Jan 2011
20 enrolled
Monitored Anesthesia Care
A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure
Started Nov 2010
10 enrolled
Lactating Women
A Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations
Started Apr 2010
153 enrolled
Sedation
Worked on LUSEDRA at Eisai? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.